Discovery of SCH446211 (SCH6): A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication

Journal Article · Mon Jun 30 00:00:00 EDT 2008 · J. Med. Chem.

DOI:https://doi.org/10.1021/jm060077j· OSTI ID:1007778

Bogen, Stephane L; Arasappan, Ashok; Bennett, Frank; Chen, Kevin; Jao, Edwin; Liu, Yi-Tsung; Lovey, Raymond G; Venkatraman, Srikanth; Pan, Weidong; Parekh, Tajel; Pike, Russel E; Ruan, Sumei; Liu, Rong; Baroudy, Bahige; Agrawal, Sony; Chase, Robert; Ingravallo, Paul; Pichardo, John; Prongay, Andrew; Brisson, Jean-Marc ; Hsieh, Tony Y; Cheng, Kuo-Chi; Kemp, Scott J; Levy, Odile E; Lim-Wilby, Marguerita; Tamura, Susan Y; Saksena, Anil K; Girijavallabhan, Viyyoor; Njoroge, F George ^[1]

---

1. SPRI

Introduction of various modified prolines at P{sub 2} and optimization of the P{sub 1} side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K*{sub i} = 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC{sub 50} and IC{sub 90} of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.

• Research Organization: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
• Sponsoring Organization: USDOE
• OSTI ID: 1007778
• Journal Information: J. Med. Chem., Vol. 49, Issue (9) ; 05, 2006; ISSN 0022-2623
• Country of Publication: United States
• Language: ENGLISH

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
99 GENERAL AND MISCELLANEOUS//MATHEMATICS, COMPUTING, AND INFORMATION SCIENCE
ENZYME INHIBITORS
ENZYMES
GENOTYPE
INTERFERON
OPTIMIZATION
REPLICONS
RNA
SERINE